Endpoint Health is a precision therapeutics company backed by top-tier Silicon Valley investors and founded by successful entrepreneurs who built and sold a previous healthcare company to Roche. Founded in 2018, we are on a mission to address urgent needs in immune-driven critical and chronic illnesses by delivering therapies that are personalized to each patient’s biology.

Endpoint combines therapeutics, diagnostics and AI into an integrated platform designed to bring targeted therapies to patients with inflammatory illnesses such as sepsis, acute respiratory distress syndrome (ARDS), rheumatoid arthritis and inflammatory bowel disease (IBD). Our vision is a world in which all patients have effective, personalized treatment, because therapies are targeted to the right patient at the right time.